Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Bushen formula (JPBS) is a Traditional Chinese Medicine (TCM) herbal preparation used to invigorate the spleen and tonify the kidney. It has demonstrated therapeutic effects across various conditions, including ulcerative colitis, colon cancer, osteoporotic fractures, chronic kidney disease (CKD) anemia, Alzheimer's disease, aromatase-inhibitor-associated bone loss, and gastric cancer. Its mechanisms of action are diverse, involving the promotion of intestinal stem cell differentiation, activation of the β-catenin signaling pathway, modulation of gut microbiota, anti-inflammatory effects, regulation of bone metabolism, and suppression of factors involved in pre-metastatic niche formation. JPBS has been investigated in both preclinical models and clinical trials, showing potential to improve chemotherapy completion rates in colon cancer patients and enhance various physiological parameters in other disease states.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianpi Bushen formula.